Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
541 Characterization of myeloid cell subsets in the tumor microenvironment of merkel cell carcinomaTabachnick-Cherny, S. ; Pulliam, T. ; Smythe, K. ; Nghiem, P.Journal of investigative dermatology, 2022-08, Vol.142 (8), p.S92 [Periódico revisado por pares]Texto completo disponível |
|
2 |
Material Type: Artigo
|
143 Genetic and transcriptional signatures of merkel cell carcinoma-specific B cells suggest a functional role in modulating cancer immunityRemington, A.J. ; Rodriguez, H.J. ; Pulliam, T. ; Gray, M.D. ; Taylor, J.J. ; Nghiem, P.Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S24-S24 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
434 Novel management approaches for oligometastatic merkel cell carcinoma when standard systemic therapy is not an optionMcClure, E. ; Akaike, T. ; Huynh, E.T. ; Harikrishnan, N. ; Lachance, K. ; Church, C. ; Pulliam, T. ; Nghiem, P.Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S75-S75 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
4 |
Material Type: Artigo
|
848 Inhibition of ATR augments immunogenicity in merkel cell carcinoma: A promising approach to address resistance to anti-PD-1 immunotherapyBhakuni, R. ; Goff, P. ; Lee, J.H. ; Pulliam, T. ; Tabachnick-Cherny, S. ; Morningstar, C.D. ; Nghiem, P.Journal of investigative dermatology, 2022-08, Vol.142 (8), p.S147 [Periódico revisado por pares]Texto completo disponível |
|
5 |
Material Type: Artigo
|
LB879 Friend or foe? Identification of MCPyV-specific B cells in Merkel cell carcinomas suggests a functional role in tumor immunityChevez, H. J. Rodriguez ; Pulliam, T. ; Remington, A. ; Nghiem, P. ; Taylor, J.Journal of investigative dermatology, 2022-08, Vol.142 (8), p.B3 [Periódico revisado por pares]Texto completo disponível |
|
6 |
Material Type: Artigo
|
LB820 ATR inhibition for potentiation of immunogenicity and cell death in Merkel Cell Carcinoma refractory to PD-1 pathway blockadeBhakuni, R. ; Goff, P. ; Lee, J. ; Pulliam, T. ; Cherny, S. ; Morningstar, C.D. ; Nghiem, P.Journal of investigative dermatology, 2021-09, Vol.141 (9), p.B28-B28 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
7 |
Material Type: Artigo
|
865 Immunotherapy in advanced Merkel cell carcinoma: Frequent responses but a potentially concerning recurrence rate after therapy discontinuationMoshiri, Y. ; Alexander, N. ; Akaike, T. ; Doolittle-Amieva, C. ; Pulliam, T. ; Zaba, L. ; Nghiem, P.Journal of investigative dermatology, 2020-07, Vol.140 (7), p.S113-S113 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
8 |
Material Type: Artigo
|
LB1029 Correlation of merkel virus-specific CD8 T cells with response to immunotherapy in merkel cell carcinomaPulliam, T. ; Jani, S. ; Jing, L. ; Zhang, J. ; Kulikauskas, R. ; Church, C. ; Garnett-Benson, C. ; Paulson, K. ; Pardoll, D. ; Koelle, D. ; Topalian, S. ; Nghiem, P.Journal of investigative dermatology, 2022-08, Vol.142 (8), p.B36 [Periódico revisado por pares]Texto completo disponível |
|
9 |
Material Type: Artigo
|
LB1044 Inhibitors of CDK4/6 and HIF2a induce immunogenic cell death in merkel cell carcinoma cellsLee, J.H. ; Lee, J. ; Pulliam, T. ; Paulson, K. ; Voillet, V. ; Berndt, A. ; Church, C. ; Lachance, K. ; Park, S.Y. ; Cromwell, E. ; Gottardo, R. ; Chapuis, A. ; Nghiem, P.Journal of investigative dermatology, 2022-08, Vol.142 (8), p.B38 [Periódico revisado por pares]Texto completo disponível |
|
10 |
Material Type: Artigo
|
292 Is it safe to discontinue immunotherapy after a response in merkel cell carcinoma?Tachiki, L. ; Zawacki, L. ; Hippe, D. ; Moshiri, Y. ; Alexander, N. ; Akaike, T. ; Doolittle-Amieva, C. ; Pulliam, T. ; Zaba, L. ; Bhatia, S. ; Nghiem, P.Journal of investigative dermatology, 2022-08, Vol.142 (8), p.S50 [Periódico revisado por pares]Texto completo disponível |